LIM
BIIB icon

Longfellow Investment Management’s Biogen BIIB Stock Holding History

Longfellow Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13
Closed -$3K – 365
2022
Q1 		$3K Hold
13
– – ﹤0.01% 310
2021
Q4 		$4K Hold
13
– – ﹤0.01% 315
2021
Q3 		$4K Hold
13
– – ﹤0.01% 342
2021
Q2 		$5K Buy
13
+3
+30% +$909 ﹤0.01% 347
2021
Q1 		$3K Hold
10
– – ﹤0.01% 420
2020
Q4 		$3K Buy
+10
New +$2.58K ﹤0.01% 441

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Longfellow Investment Management's BIIB Position: Q2 2022 in Review

Longfellow Investment Management sold out of Biogen (BIIB) in Q2 2022, closing a stake of 13 shares — an estimated $3K sold.

Longfellow Investment Management first reported a position in BIIB in Q4 2020 and held it in 6 quarters. The position peaked at $5K in Q2 2021. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Longfellow Investment Management reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Longfellow Investment Management sold 13 Biogen shares in Q2 2022, an estimated $3K.
  • Longfellow Investment Management first reported a position in Biogen in Q4 2020 and held it in 6 quarters.
  • Longfellow Investment Management's Biogen position peaked at $5K in Q2 2021.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Longfellow Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.